clarithromycin has been researched along with Cholera Infantum in 38 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 12 (31.58) | 18.2507 |
| 2000's | 17 (44.74) | 29.6817 |
| 2010's | 9 (23.68) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Engidawork, E; Gebeyehu, E; Nigatu, D | 1 |
| Bozdag, S; Dilmen, U; Erdeve, O; Gokmen, T; Oguz, SS; Ozdemir, R; Uras, N | 1 |
| Gotoda, T; Iwatsuka, K; Kusano, C; Moriyama, M; Suzuki, S | 1 |
| Pan, WS; Yan, XF; Zeng, S; Zhou, Q; Zhu, LL | 1 |
| Baranov, AA; Shcherbakov, PL | 1 |
| Frydendall, N; Gluud, C; Hansen, JF; Hilden, J; Jespersen, CM; Kolmos, HJ | 1 |
| Angelini, R; Pontone, P; Pontone, S; Standoli, M | 1 |
| Mukherji, S; Ramanathan, S; Tarin, S | 1 |
| Abbas, Z; Abid, S; Jafri, SN; Yakoob, J | 1 |
| de Vrese, M; Kristen, H; Laue, C; Rautenberg, P; Schrezenmeir, J | 1 |
| Doosti, A; Ghorbani-Dalini, S; Kargar, M; Souod, N | 1 |
| Ashida, C; Higashida, A; Kuwada, T; Mamori, S; Mitsuoka, T; Senda, E; Suga, Y; Taki, M; Yamada, H | 1 |
| Guchev, IA; Klochkov, OI; Ul'ianov, VA | 1 |
| Hoshino, Y; Ishii, H; Kurabayashi, K; Masaoka, T; Minegishi, Y; Nomura, S; Suzuki, H; Suzuki, M | 1 |
| Fujimura, S; Iinuma, K; Kato, S; Watanabe, A | 1 |
| Chey, WD; Saad, R | 1 |
| Niv, Y | 1 |
| Hibi, T; Ishii, H; Masaoka, T; Sakai, G; Suzuki, H | 1 |
| Konno, M | 1 |
| Cheng, H; Hu, FL; Li, J | 1 |
| Fujioka, T; Fujiyama, K; Kawasaki, H; Kodama, R; Kubota, T; Nasu, M | 1 |
| Böttger, EC; Böttger, O; Stichnoth, DO | 1 |
| Haber, M; Kidd, S; Krause, R; Rose, P; Sahba, B; Schwartz, H; Siepman, N; Weissfeld, A | 1 |
| Cunnane, K; Kelly, S; Laundon, J; McLoughlin, R; O'Connor, HJ | 1 |
| Wiedermann, BL | 1 |
| Unge, P | 1 |
| Tytgat, GN; van 't Hoff, BW; van der Ende, A; van der Hulst, RW | 1 |
| Abdul Aal, G; Abdul Rasheed, Z; Awad, S; Dajani, AI; Gautam, S; Nayal, S; Nounou, MA; Ukabam, S | 1 |
| Fukuchi, S; Hayakawa, K; Matsuoka, M; Sugano, K; Yoshida, Y | 1 |
| Daudén, E; García-Díez, A; Jiménez-Alonso, I | 1 |
| Benner, R; Bissett, J; Boulos, M; Cahn, P; Dickenson, G; Dunne, M; Fessel, J; Green, S; Hicks, C; Keiser, P; Kumar, P; Lewi, D; Mogyros, M; O'Connor, M; Schneider, MM; Tilles, J; White, AC | 1 |
| Fallone, CA; Hunt, RH; Sherman, PM; Smaill, FM; Thomson, AB; Veldhuyzen van Zanten, SJ | 1 |
| Bozzola, L; Di Mario, F; Franceschi, M; Furlan, F; Leandro, G; Pilotto, A; Rassu, M | 1 |
| Antonenko, OM; Dicheva, DT; Lebedev, EG; Maev, IV; Ovsiannikova, EV; Shchekina, MI; V'iuchnova, ES | 1 |
| Bujanda, L; Cosme, A; Iriondo, C; Muñoz, C; Sánchez, A; Santos, A | 1 |
| Anderson, G | 1 |
| Wood, MJ | 1 |
| Scaglione, F | 1 |
11 review(s) available for clarithromycin and Cholera Infantum
| Article | Year |
|---|---|
Current consensus on the diagnosis and treatment of H. pylori-associated gastroduodenal disease.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Animals; Apoptosis; Chemistry, Clinical; Clarithromycin; Drug Therapy, Combination; Gastric Mucosa; Gastrointestinal Diseases; Gerbillinae; Helicobacter Infections; Helicobacter pylori; Japan; Lansoprazole; Omeprazole; Peptic Ulcer; Urease | 2003 |
A clinician's guide to managing Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Diagnosis, Differential; Endoscopy; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Peptic Ulcer | 2005 |
[Helicobacter pylori eradication therapy for children].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anemia, Iron-Deficiency; Anti-Bacterial Agents; Child; Clarithromycin; Drug Resistance; Drug Therapy, Combination; Enzyme Inhibitors; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Omeprazole; Patient Compliance; Proton Pump Inhibitors; Purpura, Thrombocytopenic, Idiopathic; Treatment Outcome | 2005 |
Macrolides: clarithromycin and azithromycin.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacterial Infections; Child; Child, Preschool; Clarithromycin; Clinical Trials as Topic; Drug Resistance, Microbial; Female; Gastrointestinal Diseases; Humans; Male | 1998 |
Antibiotic treatment of Helicobacter pylori infection.
Topics: Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Randomized Controlled Trials as Topic | 1999 |
[Treatment of Helicobacter pylori infections].
Topics: Clarithromycin; Clinical Protocols; Drug Resistance; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Metronidazole; Proton Pump Inhibitors; Stomach Neoplasms; Stomach Ulcer | 1999 |
Helicobacter pylori and idiopathic chronic urticaria.
Topics: Adult; Age Factors; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Carbon Isotopes; Case-Control Studies; Chronic Disease; Clarithromycin; Female; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Prevalence; Turkey; Urea; Urticaria | 2000 |
Implications of antibiotic resistance in the management of Helicobacter pylori infection: Canadian Helicobacter Study Group.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Point Mutation | 2000 |
[Experience in the use of losek (omeprazole) in gastroenterology].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Gastroesophageal Reflux; Gastrointestinal Diseases; Humans; Metronidazole; Omeprazole; Penicillins; Placebos; Randomized Controlled Trials as Topic; Stomach Diseases; Stomach Ulcer; Tablets; Time Factors; Zollinger-Ellison Syndrome | 2001 |
Clarithromycin in the treatment of community-acquired lower respiratory tract infections.
Topics: Administration, Oral; Clarithromycin; Drug Resistance, Microbial; Erythromycin; Gastrointestinal Diseases; Humans; Incidence; Randomized Controlled Trials as Topic; Respiratory Tract Infections | 1991 |
The tolerance and toxicity of clarithromycin.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Aged; Clarithromycin; Clinical Trials as Topic; Drug Evaluation; Drug Interactions; Erythromycin; Female; Gastrointestinal Diseases; Humans; Incidence; Male; Middle Aged | 1991 |
14 trial(s) available for clarithromycin and Cholera Infantum
| Article | Year |
|---|---|
Clarithromycin treatment in preterm infants: a pilot study for prevention of feeding intolerance.
Topics: Anti-Bacterial Agents; Clarithromycin; Enteral Nutrition; Female; Gastrointestinal Diseases; Gastrointestinal Motility; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Male; Parenteral Nutrition; Placebos | 2013 |
Compliance with and short-term adverse events from clarithromycin versus placebo in patients with stable coronary heart disease: the CLARICOR trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Clarithromycin; Coronary Disease; Female; Gastrointestinal Diseases; Humans; Male; Middle Aged; Patient Compliance; Placebos; Young Adult | 2009 |
Efficacy of H. pylori eradication with a sequential regimen followed by rescue therapy in clinical practice.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Italy; Lansoprazole; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Treatment Outcome | 2010 |
Probiotic lactobacilli and bifidobacteria in a fermented milk product with added fruit preparation reduce antibiotic associated diarrhea and Helicobacter pylori activity.
Topics: Adult; Amoxicillin; Bifidobacterium; Breath Tests; Clarithromycin; Cultured Milk Products; Diarrhea; Double-Blind Method; Female; Fruit; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Lactobacillus acidophilus; Male; Middle Aged; Probiotics; Urea | 2011 |
[Evaluation of clarithromycin efficacy in the treatment of community-acquired pneumonia on the basis of the Binax NOW test results (a prospective open trial)].
Topics: Adolescent; Adult; Anti-Bacterial Agents; Antigens, Bacterial; Chromatography; Clarithromycin; Community-Acquired Infections; Gastrointestinal Diseases; Humans; Immunologic Techniques; Male; Military Personnel; Pneumonia, Pneumococcal; Prospective Studies; Reagent Kits, Diagnostic; Sputum; Streptococcus pneumoniae; Urticaria | 2002 |
Combination therapy with clarithromycin and sofalcone for eradication of Helicobacter pylori.
Topics: Ammonia; Anti-Bacterial Agents; Anti-Ulcer Agents; Chalcone; Chalcones; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Gastric Mucosa; Gastrointestinal Diseases; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Treatment Outcome | 1994 |
Seven-day triple therapy with lansoprazole, clarithromycin, and metronidazole for the cure of Helicobacter pylori infection: a short report.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Clarithromycin; Diarrhea; Drug Administration Schedule; Drug Evaluation; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Female; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Safety; Taste Disorders; Treatment Outcome | 1996 |
Lansoprazole triple therapy for Helicobacter pylori--is 5 days enough?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Clarithromycin; Diarrhea; Drug Therapy, Combination; Endoscopes; Female; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Nausea; Omeprazole; Patient Compliance; Peptic Ulcer; Prospective Studies; Taste Disorders; Time Factors; Treatment Outcome | 1998 |
One-week triple regime therapy consisting of pantoprazole, amoxicillin and clarithromycin for cure of Helicobacter pylori-associated upper gastrointestinal diseases.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Amoxicillin; Anti-Ulcer Agents; Benzimidazoles; Biopsy; Clarithromycin; Colony Count, Microbial; Drug Therapy, Combination; Endoscopy, Digestive System; Female; Follow-Up Studies; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Intestinal Mucosa; Male; Omeprazole; Pantoprazole; Sulfoxides; Treatment Outcome | 1999 |
A randomized, double-blind trial comparing azithromycin and clarithromycin in the treatment of disseminated Mycobacterium avium infection in patients with human immunodeficiency virus.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Gastrointestinal Diseases; Humans; Male; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Survival Analysis; Treatment Outcome | 2000 |
Incidence of secondary Helicobacter pylori resistance to antibiotics in treatment failures after 1-week proton pump inhibitor-based triple therapies: a prospective study.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Female; Gastrointestinal Agents; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Treatment Failure | 2000 |
[Comparative study of the eradication of Helicobacter pylori: ranitidine bismuth citrate versus omeprazole plus two antibiotics for seven days].
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Prospective Studies; Ranitidine | 2001 |
Clarithromycin in the treatment of community-acquired lower respiratory tract infections.
Topics: Administration, Oral; Clarithromycin; Drug Resistance, Microbial; Erythromycin; Gastrointestinal Diseases; Humans; Incidence; Randomized Controlled Trials as Topic; Respiratory Tract Infections | 1991 |
Comparison of the clinical and bacteriological efficacy of clarithromycin and erythromycin in the treatment of streptococcal pharyngitis.
Topics: Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Clarithromycin; Erythromycin; Female; Gastrointestinal Diseases; Humans; Male; Outpatients; Pharyngitis; Randomized Controlled Trials as Topic; Streptococcal Infections; Streptococcus pyogenes | 1990 |
14 other study(ies) available for clarithromycin and Cholera Infantum
| Article | Year |
|---|---|
Self-reported adverse drug effects and associated factors among H. pylori infected patients on standard triple therapy: Prospective follow up study.
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Body Mass Index; Clarithromycin; Female; Follow-Up Studies; Gastrointestinal Diseases; Helicobacter Infections; Humans; Male; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Self Report; Young Adult | 2019 |
The Efficacy and Tolerability of a Triple Therapy Containing a Potassium-Competitive Acid Blocker Compared With a 7-Day PPI-Based Low-Dose Clarithromycin Triple Therapy.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Monitoring; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Proton Pump Inhibitors; Pyrroles; Rabeprazole; Retrospective Studies; Sulfonamides; Treatment Outcome | 2016 |
Drug utilization of clarithromycin for gastrointestinal disease treatment.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; China; Clarithromycin; Clinical Audit; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Drug Utilization Review; Female; Gastrointestinal Diseases; Helicobacter Infections; Hospitals, General; Humans; Male; Middle Aged; Outpatients; Postprandial Period; Protein Synthesis Inhibitors; Retrospective Studies; Young Adult | 2008 |
[Topical issues of paediatric gastroenterology].
Topics: Child; Clarithromycin; Drug Therapy, Combination; Gastroenterology; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Hydroxybenzoates; Nitrofurans; Omeprazole; Pediatrics; Randomized Controlled Trials as Topic | 2008 |
Uveal effusion associated with Campylobacter jejuni infection presenting as bilateral angle closure glaucoma.
Topics: Acute Disease; Anti-Bacterial Agents; Campylobacter Infections; Campylobacter jejuni; Choroid Diseases; Clarithromycin; Exudates and Transudates; Eye Infections; Feces; Gastrointestinal Diseases; Glaucoma, Angle-Closure; Humans; Intraocular Pressure; Male; Middle Aged; Prednisolone | 2011 |
Antibiotic susceptibility patterns of Helicobacter pylori and triple therapy in a high-prevalence area.
Topics: Adolescent; Adult; Age Factors; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Female; Gastrointestinal Diseases; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Pakistan; Prevalence; Statistics as Topic; Stomach Ulcer; Treatment Outcome; Young Adult | 2010 |
Real-time PCR for Helicobacter pylori quantification and detection of clarithromycin resistance in gastric tissue from patients with gastrointestinal disorders.
Topics: Anti-Bacterial Agents; Bacterial Load; Clarithromycin; Cross-Sectional Studies; Drug Resistance, Bacterial; Gastrointestinal Diseases; Gastrointestinal Tract; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Point Mutation; Real-Time Polymerase Chain Reaction; RNA, Ribosomal, 23S | 2012 |
Effectiveness of esomeprazole-based triple therapy of H. pylori in young patients in Japan.
Topics: Adult; Age Factors; Aged; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Cohort Studies; Drug Therapy, Combination; Esomeprazole; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Metronidazole; Middle Aged | 2013 |
In vitro exposure to macrolide antibiotics in Helicobacter pylori strains isolated from children.
Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Clarithromycin; Drug Resistance, Bacterial; Gastrointestinal Diseases; Genes, rRNA; Helicobacter Infections; Helicobacter pylori; Humans; Macrolides; Microbial Sensitivity Tests; Mutation; RNA, Ribosomal, 23S | 2004 |
Effectiveness of omeprazole- versus lansoprazole-based triple therapy for Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Israel; Lansoprazole; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Retrospective Studies; Treatment Outcome | 2005 |
Improvement of gastrointestinal quality of life scores in cases of Helicobacter pylori-positive functional dyspepsia after successful eradication therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abdominal Pain; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Dyspepsia; Female; Gastrointestinal Diseases; Gastrointestinal Motility; Gastrointestinal Tract; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Pain Measurement; Quality of Life; Stomach Ulcer; Surveys and Questionnaires | 2005 |
[Influence of resistance of Helicobacter pylori to antibiotics on the Helicobacter pylori eradication regimens].
Topics: Adolescent; Adult; Age Factors; Aged; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Female; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Sex Factors | 2006 |
Prophylaxis of mycobacterial infection and acquired drug resistance.
Topics: AIDS-Related Opportunistic Infections; Clarithromycin; Drug Resistance, Microbial; Gastrointestinal Diseases; Humans; Models, Biological; Mutation; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifabutin | 1997 |
Simultaneous colonisation of Helicobacter pylori with and without mutations in the 23S rRNA gene in patients with no history of clarithromycin exposure.
Topics: Adult; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Gastrointestinal Diseases; Helicobacter pylori; Humans; Male; Middle Aged; Point Mutation; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; RNA, Ribosomal, 23S | 1999 |